Botanical species · safety record

Baptisia tinctoria

The EFSA Compendium of Botanicals holds 4 constituent measurements for Baptisia tinctoria. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Baptisia tinctoria (L.) Vent.

4Constituent measurements

0Safety records

2Cited sources

101Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 101 licensed products naming Baptisia tinctoria as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Dried subterranean parts
Fresh underground part(s)
Fresh underground parts
Herb extract
Radix
Rhizome
Rhizome(s)
Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(-)-sparteine	Roots and other underground parts	Solvent extraction	0.08 Percent	UV/VIS spectroscopy (photometry)	No resolvable identifier
Cytisine	Roots and other underground parts	Solvent extraction	0.244 Percent	UV/VIS spectroscopy (photometry)	No resolvable identifier
Cytisine	Roots and other underground parts	Solvent extraction	2.85 Percent	Unspecified	No resolvable identifier
N-methylcytisine	Roots and other underground parts	Solvent extraction	0.022 Percent	UV/VIS spectroscopy (photometry)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Oung-Boran., Lebreton, Philippe., Netien, Georges. Biochemical and pharmacological study of Baptisia australis. Planta medica, 1969, vol. 17, no. 4, p. 301-18.
Plugge, Pieter C. Identity of baptitoxine and cytisine. Archiv der pharmazie (weinheim, germany), 1895, vol. 233, p. 294-9.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature